Search for: "Hyman Phelps McNamara" Results 61 - 80 of 403
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Sep 2010, 6:53 am by FDABlog HPM
Join Hyman, Phelps & McNamara, P.C. attorneys on October 8, 12:00 p.m. – 1:30 p.m. for a free webinar on a very important, timely topic.  [read post]
10 Nov 2013, 3:34 pm by FDABlog HPM
An article published in the current edition of Regulatory Focus, the flagship publication of the Regulatory Affairs Professionals Society (RAPS), and authored by Hyman, Phelps & McNamara, P.C. [read post]
4 Feb 2014, 5:32 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. is participating in the Food and Drug Law Institute's Food Week 2014 being held February 10–13 in Washington, D.C. [read post]
29 Sep 2010, 6:24 am by FDABlog HPM
Hyman, Phelps & McNamara, P.C.’s Douglas Farquhar and Ricardo Carvajal will be presenting at FDLI’s upcoming two-day conference on FDA enforcement and litigation.  [read post]
11 Jul 2016, 2:18 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks two attorneys to help with our fast-growing and robust practice. [read post]
7 Jul 2016, 11:19 am by FDABlog HPM
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks two attorneys to help with our fast-growing and robust practice. [read post]
7 Dec 2011, 5:36 pm by FDABlog HPM
On December 2, 2011, Hyman, Phelps, & McNamara filed comments (here and here) to the controversial draft guidance on New Dietary Ingredient (“NDI”) notifications that FDA issued in July 2011.  [read post]
5 Jan 2014, 3:48 pm by FDABlog HPM
Kirschenbaum – Hyman, Phelps & McNamara, P.C. has updated the firm’s outline on the Application of the Health Care Fraud and Abuse Laws to the Marketing of Pharmaceuticals and Medical Devices. [read post]